NMPA Approval

Certolizumab Pegol Injection

Approval Number

国药准字SJ20190031

Registration Date

August 8, 2024

Previous Approval Numbers

S20190031

Drug Information

Generic Name

培塞利珠单抗注射液

Trade Name

希敏佳

Dosage Form

注射剂

Strength

200mg(1.0ml)/支（预充式注射器）

Drug Type

生物制品

Registration Date

August 8, 2024

Expiry Date

March 24, 2029

Company Address

Allée de la Recherche 60, B-1070 Bruxelles, Belgium

Company Address

Eisenbahnstrasse 2-4, 88085 Langenargen, Germany

Empowering clinical research with data-driven insights and AI-powered tools.